Denis Smirnov's Biography

Denis Smirnov, Associate Director, On Q Ity

Denis Smirnov received his Ph.D. from University of Pennsylvania. Since then he worked in various industrial and academic settings, including Immunicon/Veridex Corp and Howard Hughes Medical Institute. Denis currently is an Associate Director at On-Q-ity.

A Microfluidic System (C5) for the Selection of Circulating Tumor Cells that Utilizes both Affinity and Size Capture Technologies.

Thursday, 2 February 2012 at 14:45

Add to Calendar ▼2012-02-02 14:45:002012-02-02 15:45:00Europe/LondonA Microfluidic System (C5) for the Selection of Circulating Tumor Cells that Utilizes both Affinity and Size Capture Technologies. Circulating Tumor Cells in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com

Detection of rare circulating tumor cells (CTC) from blood promises to be valuable for cancer diagnosis, prognosis, and treatment, provided that CTCs are found in a high percentage of late-stage cancer patients. Current techniques, based on antibody affinity capture, are compromised by low efficiencies, presumably due to lack of cell surface antigen expression required for capture. We will describe a novel CTC platform combining affinity capture with size filtration capture (C5 CTC chip). Utility of this system for enumeration and characterization of circulating cells will also be described.

Add to Calendar ▼2012-02-02 00:00:002012-02-03 00:00:00Europe/LondonCirculating Tumor CellsCirculating Tumor Cells in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com

Conference Sponsors